Financial News · Live Terminal

Page 671 of 677

Bernstein Cuts EQT Price Target to $69 From $73, Maintains Outperform Rating

EQT (EQT) has an average rating of overweight and mean price target of $69.42, according to analysts polled by FactSet.Price: $58.29, Change: $-0.39, Percent Change: -0.66%

$EQT

Wire160d ago

Bernstein Adjusts Expand Energy PT to $160 From $144, Maintains Outperform Rating

Expand Energy (EXE) has an average rating of Buy and mean price target of $135.39, according to analysts polled by FactSet.Price: $98.82, Change: $-0.17, Percent Change: -0.17%

$EXE

Wire160d ago

UBS Adjusts Price Target on Andersen Group to $34 From $32, Maintains Buy Rating

Andersen Group (ANDG) has an average rating of overweight and mean price target of $31.17, according to analysts polled by FactSet.Price: $29.09, Change: $+0.84, Percent Change: +2.97%

$ANDG

Wire160d ago

Arete Research Lifts Sandisk Price Target to $1,800 From $1,000, Maintains Buy Rating

Sandisk (SNDK) has an average rating of overweight and mean price target of $872.30, according to analysts polled by FactSet.Price: $913.50, Change: $+61.73, Percent Change: +7.25%

$SNDK

Wire160d ago

TD Cowen Adjusts Price Target on Revvity to $115 From $124, Maintains Buy Rating

Revvity (RVTY) has an average rating of overweight and mean price target of $114.53, according to analysts polled by FactSet.Price: $90.26, Change: $+0.46, Percent Change: +0.52%

$RVTY

Wire160d ago

Scotiabank Adjusts Targa Resources PT to $249 From $246, Maintains Sector Outperform Rating

Targa Resources (TRGP) has an average rating of overweight and mean price target of $262.24, according to analysts polled by FactSet.Price: $243.31, Change: $+0.22, Percent Change: +0.09%

$TRGP

Wire160d ago

Jefferies Adjusts Price Target on Phillips 66 to $173 From $174, Maintains Hold Rating

Phillips 66 (PSX) has an average rating of overweight and mean price target of $181.63, according to analysts polled by FactSet.Price: $159.16, Change: $-0.09, Percent Change: -0.06%

$PSX

Wire160d ago

Jefferies Adjusts Price Target on Coterra Energy to $33 From $28, Maintains Hold Rating

Coterra Energy (CTRA) has an average rating of overweight and mean price target of $37.30, according to analysts polled by FactSet.Price: $33.29, Change: $-0.12, Percent Change: -0.36%

$CTRA

Wire160d ago

UBS Adjusts Price Target on Amgen to $400 From $390, Maintains Buy Rating

Amgen (AMGN) has an average rating of overweight and mean price target of $357.48, according to analysts polled by FactSet.Price: $350.13, Change: $-0.88, Percent Change: -0.25%

$AMGN

Wire160d ago

Goldman Sachs Adjusts Price Target on Revvity to $95 From $110, Maintains Neutral Rating

Revvity (RVTY) has an average rating of overweight and mean price target of $114.53, according to analysts polled by FactSet.Price: $90.26, Change: $+0.46, Percent Change: +0.52%

$RVTY

Wire160d ago

Arete Research Adjusts Micron Technology PT to $852 From $562, Maintains Buy Rating

Micron Technology (MU) has an average rating of Buy and mean price target of $553.10, according to analysts polled by FactSet.Price: $412.72, Change: $-7.87, Percent Change: -1.87%

$MU

Wire160d ago

Penumbra Says Storm-PE Trial Shows Improved Functional Outcomes With Thrombectomy Plus Anticoagulation

Penumbra (PEN) said Monday that 90-day results from the STORM-PE randomized controlled trial showed patients with acute intermediate-high risk pulmonary embolism treated with computer-assisted vacuum thrombectomy, or CAVT, plus anticoagulation achieved greater functional improvement than those receiving anticoagulation alone.Patients in the CAVT plus anticoagulation arm walked farther in the six-minute walk test, averaging 479 meters compared with 368 meters and reached 94% of their predicted walking distance versus 75.2% for those on anticoagulation alone. A higher proportion of patients also reported no physical limitations based on the New York Heart Association functional class scale, at 97% versus 76%.Safety outcomes through 90 days were comparable across both groups, with no device-related mortality, no additional pulmonary embolism-related deaths beyond seven days, and no difference in symptomatic recurrence.The data were presented at the Society of Interventional Radiology Annual Scientific Meeting. Penumbra said interim Strike-PE data on long-term quality of life and functional outcomes in CAVT-treated patients will be presented at the same meeting on April 15.Price: $330.63, Change: $+0.86, Percent Change: +0.26%

$PEN

Wire160d ago

Delta Air Lines to Introduce New Business-Class Suites as Part of $1 Billion Investment

Delta Air Lines (DAL) plans to debut upgraded Delta One suites on its new Airbus A350-1000 aircraft and retrofit its A330-200 and A330-300 fleets as part of a fleet-modernization program totaling more than $1 billionThe A330 refresh will add sliding privacy doors to Delta One suites for the first time, while the updated A350-1000 suites will feature longer lie-flat beds, wireless charging, larger screens, and a dedicated self-serve snack station for premium passengers, the airline said Monday on its website.Delta expects to roll out its modernized interior design across more than 800 aircraft over the next five years.Price: $66.19, Change: $-1.63, Percent Change: -2.41%

$DAL

Wire160d ago

Scotiabank Adjusts ONEOK Price Target to $92 From $91, Maintains Sector Outperform Rating

ONEOK (OKE) has an average rating of overweight and mean price target of $93.25, according to analysts polled by FactSet.Price: $86.32, Change: $+0.11, Percent Change: +0.13%

$OKE

Wire160d ago

Jefferies Cuts Price Target on Builders FirstSource to $85 From $110, Maintains Hold Rating

Builders FirstSource (BLDR) has an average rating of overweight and mean price target of $122.18, according to analysts polled by FactSet.Price: $83.69, Change: $-1.61, Percent Change: -1.89%

$BLDR

Wire160d ago

Goldman Sachs Adjusts Price Target on Danaher to $230 From $265, Maintains Buy Rating

Danaher (DHR) has an average rating of buy and mean price target of $256.90, according to analysts polled by FactSet.Price: $191.14, Change: $+1.53, Percent Change: +0.81%

$DHR

Wire160d ago

Heartflow Files Lawsuit Against Cleerly Over Alleged Patent Infringement

Heartflow (HTFL) said Monday it has lodged a patent infringement complaint against Cleerly in a Texas district court regarding the unapproved application of its coronary artery disease technology.Heartflow alleges that Cleerly's Ischemia, Plaque Analysis, and Compare products infringe six of its patents, according to a statement.Cleerly did not immediately respond to' request for a comment.Price: $26.31, Change: $-0.64, Percent Change: -2.37%

$HTFL

Wire160d ago

TD Cowen Adjusts Price Target on Danaher to $245 From $270, Maintains Buy Rating

Danaher (DHR) has an average rating of buy and mean price target of $256.90, according to analysts polled by FactSet.Price: $191.14, Change: $+1.53, Percent Change: +0.81%

$DHR

Wire160d ago

Wedbush Adjusts Price Target on Spyre Therapeutics to $80 From $65, Maintains Outperform Rating

Spyre Therapeutics, Inc (SYRE) has an average rating of buy and mean price target of $66.50, according to analysts polled by FactSet.Price: $63.57, Change: $+12.28, Percent Change: +23.94%

$SYRE

Wire160d ago

Cloudflare Announces New Features for Agent Cloud

Cloudflare (NET) said Monday it is expanding its Agent Cloud with new features to help developers build, deploy, and scale agents.The new tools allow artificial intelligence agents to move from experimental demos to production-grade workloads operating across Cloudflare's global network, the company said.Cloudflare said it was introducing Dynamic Workers, an isolate-based runtime developed to run AI-generated code in a secure, sandboxed environment, Artifacts, a Git-compatible storage primitive built for agents, and the general availability of sandboxes for when an agent needs a full operating system, according to the company.Shares of Cloudflare rose 8% in Monday trading.Price: $178.83, Change: $+11.84, Percent Change: +7.09%

$NET

Showing 13401-13420 of 13525